[Seroepidemiology of poliomyelitis in Mexico].
With the massive vaccination campaigns with the inactivated poliomyelitis vaccine starting in 1955 and its oral presentation in 1961, this disease has been controlled in many countries. However, wild polio virus is still transmitted in many developing countries. The study reported in this article had the objectives of estimating the prevalence of antibodies against polio for three types of virus (1, 2 and 3) in the population from 12 to 59 months of age in Mexico and determining the factors associated with the absence of immunity. One section of the National Seroepidemiology Survey (NSS), a study with a representative sample of the Mexican population, included the analysis of 5,260 blood samples for polio seropositivity. These samples were processed using the technique of plaque-reduction-neutralization, with the cut-off for positive titer values at 1:8. The national immunity levels reported for the three types of polio virus were: type 1 (89.8%); type 2 (97.6%); and type 3 (85.4%). The state with the lowest seroprevalence was Campeche, with 59.7 per cent, and the highest observed was Baja California Sur, with 93.0 per cent. The NSS also showed that the immunity level increases with age. There were some differences observed by place of residence; seroprevalences were higher in the urban areas (type one, 93.4%; type two, 98.5% and type three, 88.2%) than in the rural zones (86.6%, 96.8% and 82.9%, respectively). As expected, previous vaccination with three or more doses, referred verbally by the parent or guardian of the child, was associated with higher positivity.(ABSTRACT TRUNCATED AT 250 WORDS)
Ruiz-Gómez
J
J
Instituto Nacional de Diagnóstico y Referencia Epidemiológicos, SSA, México.
Tapia-Conyer
R
R
Salvatierra
B
B
Quiroz
G
G
Magos
C
C
Llausás
A
A
Gutiérrez
G
G
Sepúlveda
J
J
D000914:Antibodies, Viral / Q000097:blood*; D002675:Child, Preschool; D005260:Female; D006306:Health Surveys; D006801:Humans; D015994:Incidence; D007223:Infant; D008297:Male; D008800:Mexico / Q000453:epidemiology; D011051:Poliomyelitis / Q000453:epidemiology* / Q000517:prevention & control; D017955:Poliovirus / Q000276:immunology*; D011055:Poliovirus Vaccine, Oral; D015995:Prevalence; D016036:Seroepidemiologic Studies; D012959:Socioeconomic Factors; D014611:Vaccination
D000914:Antibodies, Viral; D011055:Poliovirus Vaccine, Oral
Seroepidemiología de la poliomielitis en México.